A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Daunorubicin (liposomal)

DRUG

Bleomycin sulfate

DRUG

Vincristine sulfate

DRUG

Doxorubicin hydrochloride

Trial Locations (13)

10016

New York Univ Med Ctr, New York

20037

George Washington Univ Med Ctr, Washington D.C.

33136

Univ of Miami Dept of Medicine, Miami

60611

Northwestern Univ Med School, Chicago

77004

Dr Edward Stool, Houston

85724

Univ of Arizona / Arizona Cancer Ctr, Tucson

90033

Kenneth Norris Jr Cancer Hosp, Los Angeles

92262

Desert Hosp Comprehensive Cancer Ctr, Palm Springs

94109

Saint Francis Mem Hosp, San Francisco

94114

Davies Med Ctr, San Francisco

97227

Kaiser Permanente Med Ctr, Portland

802044507

Denver Gen Hosp, Denver

02215

New England Deaconess Hosp, Boston

Sponsors
All Listed Sponsors
lead

Nexstar Pharmaceuticals

INDUSTRY